Sept 19 (Askume) – Aligos Therapeutics (ALGS.O) said on Thursday its experimental treatment for severe fatty liver disease helped significantly reduce liver fat, achieving the main goal of a mid-stage study.

    Categorized in:

    business, healthcare-pharmaceuticals,

    Last Update: September 19, 2024

    Tagged in:

    ,